Study of AZD1222 for the Prevention of COVID-19 in Japan

Trial Identifier: D8111C00002
Sponsor: AstraZeneca
Collaborator:
IQVIA
NCTID:: NCT04568031
Start Date: August 2020
Primary Completion Date: November 2021
Study Completion Date: November 2021
Condition: COVID-19 Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Japanese Version

Trial Locations

Country Location
JP Fukuoka-shi, JP, 810-0021
JP Hachioji-shi, JP, 192-0046
JP Minato-ku, JP, 108-0075
JP Sumida-ku, JP, 130-0004
JP Toshima-ku, JP, 171-0021